4
Changes in Ownership
RxSight, Inc. Filed Acc 0000950170-24-025874
Chief Financial Officer sold 10,000 shares at an average $56.37 ($563,726)
- Chief Financial Officer acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thunen Shelley B Chief Financial Officer | 2024-03-01 | Option exercise 10b5-1 | +10,000 | $15.60 | $155,983 | 23,691 | D |
| Thunen Shelley B Chief Financial Officer | 2024-03-01 | Sale 10b5-1 | −1,166 | $54.95 | $64,066 | 22,525 | D |
| Thunen Shelley B Chief Financial Officer | 2024-03-01 | Sale 10b5-1 | −6,361 | $56.38 | $358,618 | 16,164 | D |
| Thunen Shelley B Chief Financial Officer | 2024-03-01 | Sale 10b5-1 | −2,473 | $57.03 | $141,042 | 13,691 | D |
| Derivatives | |||||||
| Thunen Shelley B Chief Financial Officer | 2024-03-01 | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 56,805 | D | ||
| Open-market sales · 10,000 sh · avg $56.37 · $563,726 | |||||||
Loading xslF345X05/ownership.xml…